Trend

Mixed reading

Thyrocare Technologies promoter A Velumani mops up stock worth ₹310 million in 2019, so far

|
Published 2 years ago on Jul 12, 2019 2 minutes Read

It’s been an uneventful year for diagnostic chain Thyrocare Technologies. From a high of Rs.682 in September 2018, its stock price hit an all-time low of Rs.425 in May 2019. The stock had hit its all-time high of Rs.780 in April, 2017 post its IPO at Rs.446 a year earlier.  Mirroring investor sentiment, A Velumani, founder and CEO, noted in the company’s Q4FY19 investor meet that FY19 was a year of subdued growth.

Thyrocare’s quest to boost its topline growth in FY19 meant the company had to “sacrifice” its profitability. It lowered the prices of its popular heal

unsub

You don’t want to be left behind. Do you?

Our work is exclusively for discerning readers. To read our edgy stories and access our archives, you’ve to subscribe